Skip to Content
Webinar Recording

Zanubrutinib in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Recorded on: October 10, 2024

 

In this webinar, we explore the evolution of BTK inhibitors that are reshaping how we approach patient care for chronic lymphocytic leukemia and small lymphocytic lymphoma.

Join us as Evan Slater, PharmD, from Rocky Mountain Cancer Centers, unpacks the essential pharmacokinetics and pharmacodynamics of this promising BTK inhibitor. Gain insights into the latest exploratory studies, innovative dosing strategies, and pricing dynamics crucial for optimizing patient outcomes.